📰 Diagnostics Inc News
Page 7 - Diagnostics Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Diagnostics Inc. Real-time updates on events, politics, business and more.
February 16, 2024
Assertio (NASDAQ:ASRT – Get Free Report) and ERBA Diagnostics (OTCMKTS:ERBA – Get Free Report) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, institutional ownership and profitability. Analyst Ratings This is a summary of recent ratings […]
February 14, 2024
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Free Report) was the target of a large drop in short interest in January. As of January 31st, there was short interest totalling 359,600 shares, a drop of 36.9% from the January 15th total of 570,000 shares. Based on an average daily volume of 109,500 shares, the short-interest ratio is […]
February 14, 2024
On February 5, 2024, Judge Arun Subramanian of the United States District Court for the Southern District of New York largely declined to dismiss a putative class action asserting...
February 8, 2024
/PRNewswire/ - International biotechnology company, BioAro is thrilled to announce that its Whole Genome Sequencing tests are now available online North...
February 1, 2024
Co-Diagnostics, Inc. (NASDAQ:CODX – Get Free Report) saw a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 570,000 shares, a drop of 9.8% from the December 31st total of 632,000 shares. Based on an average daily volume of 109,200 shares, the short-interest ratio is […]
February 1, 2024
/PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the...
January 31, 2024
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The
January 28, 2024
StockNews.com initiated coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Free Report) in a research note released on Wednesday morning. The firm issued a hold rating on the medical research company’s stock. Accelerate Diagnostics Trading Down 5.2 % NASDAQ:AXDX opened at $1.28 on Wednesday. The stock has a market capitalization of $18.65 million, a price-to-earnings […]
January 23, 2024
/PRNewswire/ -- The "Hematological Disorders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key...
January 23, 2024
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The